Completed
Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes
NCT03824080
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- CHU Hôtel Dieu Service d'Hématologie Clinique Nantes, Nantes Cedex 1, France
- Service d'Hématologie Séniors Paris, Paris 7, France
- Hôpital Archet 1 Service d'Hématologie Clinique Nice, France
- Universitätsklinikum Dresden Dresden, Germany